| Literature DB >> 35202142 |
Zsuzsa Farkas1, Erika Országh1, Tekla Engelhardt1, Szilveszter Csorba1, Kata Kerekes2, Andrea Zentai2, Miklós Süth1, Attila Nagy3, Gabriella Miklós4, Krisztina Molnár5, Csaba Rácz5, Tamás Dövényi-Nagy5, Árpád Ambrus6, Zoltán Győri7, Attila Csaba Dobos5, Tünde Pusztahelyi8, István Pócsi9, Ákos Jóźwiak1.
Abstract
The study presents a systematic review of published scientific articles investigating the effects of interventions aiming at aflatoxin reduction at the feed production and animal feeding phases of the milk value chain in order to identify the recent scientific trends and summarize the main findings available in the literature. The review strategy was designed based on the guidance of the systematic review and knowledge synthesis methodology that is applicable in the field of food safety. The Web of Science and EBSCOhost online databases were searched with predefined algorithms. After title and abstract relevance screening and relevance confirmation with full-text screening, 67 studies remained for data extraction, which were included in the review. The most important identified groups of interventions based on their mode of action and place in the technological process are as follows: low-moisture production using preservatives, acidity regulators, adsorbents and various microbiological additives. The results of the listed publications are summarized and compared for all the identified intervention groups. The paper aimed to help feed producers, farmers and relevant stakeholders to get an overview of the most suitable aflatoxin mitigation options, which is extremely important in the near future as climate change will likely be accompanied by elevated mycotoxin levels.Entities:
Keywords: aflatoxin; aflatoxin mitigation; control strategies; dairy production chain; feed and farm interventions; maize contamination
Mesh:
Substances:
Year: 2022 PMID: 35202142 PMCID: PMC8878089 DOI: 10.3390/toxins14020115
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Systematic review knowledge synthesis process flow diagram.
Key characteristics of the interventions assessed.
| Study Design | Was the Dose–Response Gradient Measured? | Sum | ||
|---|---|---|---|---|
| No | Yes | Not Specified | ||
| 1. Experimental research | 52 | 16 | 68 | |
| 1.1. Randomized controlled trial | 26 | 14 | 40 | |
| 1.2. Challenge trial | 1 | 1 | ||
| 2. Observational research | 3 | 3 | ||
| 3. Narrative review | 3 | 11 | 14 | |
Summary of the main findings of the studies on adsorbents and their combinations, as well as toxin-binding premixes in aflatoxin (AF) mitigation.
| Adsorbents | In Vitro | In Vivo | Animal Health Status/Zootechnical Parameters | Other | Remarks | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AF Adsorption/Binding | Antifungal Activity | Ruminal Fermentation Parameters | AF Degradation/Reduction in Animals 1 | Carryover/Transfer Rate | Reduction in AF Excretion 2 | Blood (Plasma) Parameters 3 | Performance, e.g., Milk Yield, Feed Intake, Milk Composition | General Health Status | Immune Status | ||||
| Alam et al. (2015) [ | Smectite | ++ | Effects of glucose and ethanol on AFB1 adsorption by smectites; at least 90% of the smectites’ AFB1 adsorption capacity was preserved even with high concentrations of ethanol and glucose | ||||||||||
| Antonelo et al. (2017) [ | Smectite | ++ | Linear toxin dose effect | ||||||||||
| Maki et al. (2016a) [ | Calcium montmorillonite | ++ | ++ | 0 | 0 | Dose-dependent reduction of the AFM1 concentration | |||||||
| Maki et al. (2016b) [ | Calcium montmorillonite | ++ | ++ | ++ | 0 | 0 | Dose-dependent reduction of the AFM1 concentration | ||||||
| Pate et al. (2018) [ | Aluminosilicate clay | ++ | 0 | ||||||||||
| Sulzberger et al. (2017) [ | Clay-containing vermiculite, nontronite and montmorillonite | + | + | + | + | 0 | 0 | ||||||
| Soufiani et al. (2016) [ | Activated montmorillonite clay/nonactivated montmorillonite clay/commercially available clay binder (G.Bind) | +/+/++ | +/+/++ | ||||||||||
| Akhtar et al. (2016) [ | Glucomannan/hydrated sodium calcium aluminosilicates (HSCAS)/activated charcoal | ++/+/+ | ++/+/+ | ||||||||||
| Jiang et al. (2014) [ | Bamboo charcoal/smectite | ++/+ | ++/++ | ||||||||||
| Rojo et al. (2014) [ | Aluminosilicate adsorbents/yeast cell wall glucomannan | ++/+ | ++/+ | ||||||||||
| Kissel et al. (2012) [ | Glucomannan and aluminosilicate blend/modified glucomannan/Alltech product (ingredients not specified in the study)/sodium bentonite | 0/0/++ | |||||||||||
| Jiang et al. (2018) [ | Bentonite clay/bentonite clay with a | +/+ | +/+ | + | + | ||||||||
| Weatherly et al. (2018) [ | Yeast fractions and bentonite | + | 0 | 0 | + | 0 | A quadratic trend was observed for AFB1 presence in faeces | ||||||
| Ramales-Valderrama et al. (2016) [ | ++/+/++ | According to the analysis of zeta (or electrokinetic) potential, the authors concluded that the interaction type between aflatoxins and the biosorbent is primarily electrostatic. According to FTIR analysis, hydroxyl, amine, carboxyl, amide, phosphate and ketone groups are likely responsible for biosorption of AFB1 molecules | |||||||||||
| Naseer et al. (2018) [ | Garlic ( | +/+/+ | According to the results of feed sample analyses ( | ||||||||||
| Fani-Makki et al. (2018) [ | Milk thistle ( | ++ | The mechanism by which MT seeds decrease AFB1 is not fully understood. The presence of fibre in the seeds acting as adsorbents, silymarin, a natural polyphenolic flavonoid, and polyunsaturated fatty acids may also contribute to the beneficial characteristics regarding aflatoxin diminishing | ||||||||||
| Rychen et al. (2016) [ | Algae interspaced bentonite | ++ | |||||||||||
| Xiong et al. (2018) [ | Solis mos (sodium montmorillonite, live yeast, yeast culture, mannan oligosaccharide and vitamin E) | ++ | ++ | ++ | 0 | ||||||||
| Xiong et al. (2015) [ | Solis mos (sodium montmorillonite, live yeast, yeast culture, mannan oligosaccharide and vitamin E) | + | ++ | ++ | ++ | + | No effect was detected when the adsorbent was added to the diet containing a higher level of AFB1 | ||||||
| Jovaisiene et. al. (2016) [ | Mycofix Plus 3.E (mineral components, biological constituent, live organism, phytogenic substances, phycophytic constituents) | 0/+ | + | Decrease in urea in the treatment groups, but other biochemistry data showed no change. Non-significant change in the immunity status | |||||||||
| Aslam et al. (2016) [ | 50/50% mixture of Mycofix Secure (bentonite/dioctahedral montmorillonite) and Mycofix Plus (bentonite/dioctahedral montmorillonite, Biomin BBSH 797, Biomin MTV ( | + | + | ||||||||||
| Naveed et al. (2018) [ | Fixar Viva/Mycosorb/T5X (ingredients not specified) | ++ | ++ | ++ | ++ | ||||||||
| Ullah et al. (2016) [ | Toxfin (sepiolite, bentonite and companion clays)/Elitox (enzymes, HSCAS, biopolymers, vitamin C and natural extracts) | ++ | + | ||||||||||
| Ogunade et al. (2016) [ | 0 | 0 | 0 | ++/+/+ | When AFB1 was withdrawn from the diet, AFM1 concentrations decreased rapidly in the treatment groups, such that they fell below the FDA action level within 24 h, whereas it took 48 h in case of the control group (only the toxin) | ||||||||
Legend: ++—significant; +—not significant or not indicated in the study; 0—no change; empty cell—not examined. Different results for different food additives examined in the same study are separated with “/”. 1 Parameters such as aflatoxin levels in blood, urine, faeces, milk. 2 Generally calculated from the AFM1 concentration and milk yield. 3 Including liver and kidney functions (if measured).
Summary of the main findings of the studies on the effect of microbes and enzymes on aflatoxin (AF) mitigation.
| Microbes and Enzymes | In Vitro | In Vivo | Animal Health Status/Zootechnical Parameters | Other Experiments | Remarks | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AF Adsorption/Binding | Antifungal Activity AF Inhibition | AF Degradation/Detoxification in Feed | AF Degradation/Reduction in Animals 1 | Extinguishing AF Immunomodulation | Extinguishing AF Genotoxic Effect | Extinguishing AF Cytotoxic Effect | |||||
| Dogi et al. (2017) [ | + | AFB1 effect on | |||||||||
| Gonzales Pereyra et al. (2014) [ | ++ | 0 | 0/+ | ||||||||
| Magnoli et al. (2016) [ |
| + | AFB1 desorption study—irreversible binding was shown | All the tested strains were able to bind AFB1; however, the highest AFB1 affinity was observed for | |||||||
| Poloni et al. (2015) [ | 0 | Potentiation of a feed additive premix by different strains was investigated | |||||||||
| Poloni et al. (2015) [ | ++ | Potentiation of a feed additive premix by different strains was investigated | |||||||||
| Poloni et al. (2015) [ | ++ | Potentiation of a feed additive premix by different strains was investigated | |||||||||
| Gonçalves et al. (2017) [ |
| ++ | 0 | ||||||||
| Tayel et al. (2013) [ | + | + | Hydrolytic enzyme secretion experiment—β-1,3-glucanase and exo-chitinase activity | ||||||||
| Dogi et al. (2015) [ | ++ | ||||||||||
| Zielinska and Fabiszewska (2018) [ | ++ | Studies relating to the synergistic activity of bacterial strains were also conducted on a production scale. It resulted in a decrease in mould count and a decrease in AFB1 levels in silages by 74% and 75%, respectively, compared to the negative control | The bacterial strains had a synergistic effect and decreased the AFB1 levels by about 80% compared to the control silage and by about 74% compared to the silage inoculated with only one strain ( | ||||||||
| Ying et al. (2017) [ |
| ++ | Fermentation characteristics, in vitro digestibility—positive effects | Reduction of aflatoxin production in silage was investigated during exposure to air | |||||||
| Ma et al. (2017) [ | Ten | ++ | Viability and pH studies on binding: the greatest binding of AFB1 within a bacterium was achieved by dead | When applied at 109 CFU/mL, all the 10 bacteria bound AFB1, but | |||||||
| Drobná et al. (2017) [ | ++ | ++ | pH studies—the highest inhibition of fungal growth was observed at pH 4 | The highest growth inhibition of | |||||||
| Rather et al. (2014) [ | ++ | ++ | + | ||||||||
| Dogi et al. (2013) [ | ++ | Antibiotic resistance—no genes for resistance to the tested antibiotics | |||||||||
| Dogi et al. (2013) [ | ++ | - | Inhibition only at pH 4 | ||||||||
| Nasrabadi et al. (2013) [ | + | + | ++ | ||||||||
| Jebali et al. (2015) [ | ++ | ++ | ++ | ||||||||
| Zhang et al. (2019) [ | ++ | + | Single dose of AFB1 administration | ||||||||
| Ben Salah-Abbés et. al. (2015) [ | ++ | ++ | ++ | ++ | Live LP showed better binding percentages than heat-killed LP | ||||||
| Intanoo et al. (2018) [ | Ruminal fluid isolates— | ++ | Preliminary assessment on biomass production—the isolates could be produced in bulk for their potential use as feed supplements for dairy cattle | The best yeast isolates were identified as | |||||||
| Wang et al. (2018) [ | Microbial consortium TMDC ( | ++ | Simultaneous degradation of AFB1 and ZEA was studied | Cell-free supernatants, cell pellets and intracellular extracts of TMDC were studied. Supernatants of TMDC played a dominant role in mycotoxin degradation by the microbial consortium. | |||||||
| Wang et al. (2019) [ | ++ | Temperature studies—the active component might be heat-resistant; pH studies—degradation rates of alkaline conditions were higher than those of acidic conditions; toxicity studies—biotransformed AFB1 was less toxic | The culture supernatant showed a significantly higher degradation rate than that of intracellular extracts | ||||||||
| Prettl et al. (2017) [ | ++ | Biomass growth—changed to a stagnant state after seven days of incubation in harmony with the mycotoxin degradation rate | |||||||||
| Xu et al. (2017) [ | ++ | Enzyme characterization—thermostable enzyme named | The culture supernatant of the tested isolate was more effective than viable cells and cell extracts | ||||||||
| Scarpari et al. (2014) [ | ++ | ++ | AFB1 degradation experiments with the laccase enzyme—significant decrease under in vitro and in vivo conditions (liquid culture and maize). Toxicity study of the AFB1 by-product of the laccase enzyme—no toxic effects were shown | ||||||||
| Das et al. (2014) [ | ++ | Effect of metal ions and surfactants on degradation—enhanced degradation was noted for | The highest degradation was recorded for both strains at the 0.5 µg/mL initial concentration of AFB1. With an increase in AFB1 concentration, progressive decrease in degradation was encountered | ||||||||
| Branà et al. (2017) [ |
| ++ | ++ | Translocation of AFB1 and aflatoxicol through the thallus to the basidiocarps (fruit bodies)—neither the biomass produced on the mushroom substrate nor the mature basidiocarps contained detectable levels of AFB1 or its metabolite aflatoxicol | The addition of 5% wheat straw to the culture medium increased the tolerance of | ||||||
Legend: ++—significant; +—not significant or not indicated in the study; 0—no change; -—negative effect; empty cell—not examined. Results of the same publication are indicated with a thick frame. 1 Parameters such as carryover rate, aflatoxin excretion, aflatoxin levels in blood, urine, faeces, milk.
Point in the food chain: storage and feed-producing facility.
| Search Date | 28 March 2019 |
|---|---|
| Databases | EBSCOhost |
| Intervention phase | Storage and feed-producing facility |
| Search string | TI (aflatoxin OR “aflatoxin B*” OR “aflatoxin M*” OR AFM* OR AFB* OR Aspergillus) AND TI Feed AND TI (maize OR “zea mays” OR corn) AND TI (storage OR silo-bag OR rotation OR aeration OR (modif* atmosphere) OR pest control OR insect control OR rodent control OR preservation OR “aflatoxin reduc*” OR torrefaction OR irradiat* OR ammonia* OR acidificat* OR microorganism transformation OR enzymatic transformation OR (solvent extract*) OR roughage* OR forage* OR silage OR ensilage* OR silage additive* OR “by-products” OR cgf OR corn gluten feed OR ddgs OR distillers dried grain* with soluble* OR whey OR buttermilk OR permeate OR concentrate* OR biotransform* OR degrad* OR binding OR adsorbent* OR absorbent* OR clay or HSCAS OR “sodium calcium aluminosilicate” OR charcoal OR bentonite OR zeolite OR clinoptilolite OR silicate* OR chlorofillin OR “lactic acid bacteri*” OR ferment*) |
| Field | TI (title) |
| Search mode | |
| Filters | 1 January 2013–28 March 2019 |
| Number of records | 0 |
Point in the food chain: storage and feed-producing facility.
| Search Date | 28 March 2019 |
|---|---|
| Databases | EBSCOhost |
| Intervention phase | Storage and feed-producing facility |
| Search string | AB (aflatoxin OR “aflatoxin B*” OR “aflatoxin M*” OR AFM* OR AFB* OR Aspergillus) AND AB Feed AND AB (maize OR “zea mays” OR corn) AND (storage OR silo-bag OR rotation OR aeration OR (modif* atmosphere) OR pest control OR insect control OR rodent control OR preservation OR “aflatoxin reduc*” OR torrefaction OR irradiat* OR ammonia* OR acidificat* OR microorganism transformation OR enzymatic transformation OR (solvent extract*) OR roughage* OR forage* OR silage OR ensilage* OR silage additive* OR “by-products” OR cgf OR corn gluten feed OR ddgs OR distillers dried grain* with soluble* OR whey OR buttermilk OR permeate OR concentrate* OR biotransform* OR degrad* OR binding OR adsorbent* OR absorbent* OR clay or HSCAS OR “sodium calcium aluminosilicate” OR charcoal OR bentonite OR zeolite OR clinoptilolite OR silicate* OR chlorofillin OR “lactic acid bacteri*” OR ferment*) |
| Field | AB (abstract or author-supplied abstract) |
| Search mode | |
| Filters | 1 January 2013–28 March 2019 |
| Number of records | 72 |
Point in the food chain: storage and feed-producing facility.
| Search Date | 28 March 2019 |
|---|---|
| Databases | EBSCOhost |
| Intervention phase | Storage and feed-producing facility |
| Search string | KW (aflatoxin OR “aflatoxin B*” OR “aflatoxin M*” OR AFM* OR AFB* OR Aspergillus) AND KW Feed AND KW (maize OR “zea mays” OR corn) AND KW (storage OR silo-bag OR rotation OR aeration OR (modif* atmosphere) OR pest control OR insect control OR rodent control OR preservation OR “aflatoxin reduc*” OR torrefaction OR irradiat* OR ammonia* OR acidificat* OR microorganism transformation OR enzymatic transformation OR (solvent extract*) OR roughage* OR forage* OR silage OR ensilage* OR silage additive* OR “by-products” OR cgf OR corn gluten feed OR ddgs OR distillers dried grain* with soluble* OR whey OR buttermilk OR permeate OR concentrate* OR biotransform* OR degrad* OR binding OR adsorbent* OR absorbent* OR clay or HSCAS OR “sodium calcium aluminosilicate” OR charcoal OR bentonite OR zeolite OR clinoptilolite OR silicate* OR chlorofillin OR “lactic acid bacteri*” OR ferment*) |
| Field | KW (author-supplied keywords)* |
| Search mode | |
| Filters | 1 January 2013–28 March 2019 |
| Number of records | 1 |
* Note that this search field does not exist in EBSCOhost anymore.
Point in the food chain: storage and feed-producing facility.
| Search Date | 26 March 2019 |
|---|---|
| Databases | Web of Science |
| Intervention phase | Storage and feed-producing facility |
| Search string | (((TS = (aflatoxin OR “aflatoxin B*” OR “aflatoxin M*” OR AFM* OR AFB* OR Aspergillus)) AND TS = (Feed)) AND TS = (maize OR “zea mays” OR corn)) AND TS = (storage OR silo-bag OR rotation OR aeration OR (modif* atmosphere) OR pest control OR insect control OR rodent control OR preservation OR “aflatoxin reduc*” OR torrefaction OR irradiat* OR ammonia* OR acidificat* OR microorganism transformation OR enzy-matic transformation OR (solvent extract*)) |
| Field | TS (topic) |
| Filters | 1 January 2013–26 March 2019 |
| Number of records | 69 |
Point in the food chain: storage and feed-producing facility.
| Search Date | 26 March 2019 |
|---|---|
| Databases | Web of Science |
| Intervention phase | Storage and feed-producing facility |
| Search string | (((TS = (aflatoxin OR “aflatoxin B*” OR “aflatoxin M*” OR AFM* OR AFB* OR Aspergillus)) AND TS = (Feed)) AND TS = (maize OR “zea mays” OR corn)) AND TS = (roughage* OR forage* OR silage OR ensilage* OR silage additive* OR “by-products” OR cgf OR corn gluten feed OR ddgs OR distillers dried grain* with soluble* OR whey OR buttermilk OR permeate OR concentrate* OR biotransform* OR degrad*) |
| Field | TS (topic) |
| Filters | 1 January 2013–26 March 2019 |
| Number of records | 105 |
Point in the food chain: storage and feed-producing facility.
| Search Date | 26 March 2019 |
|---|---|
| Databases | Web of Science |
| Intervention phase | Storage and feed-producing facility |
| Search string | (((TS = (aflatoxin OR “aflatoxin B*” OR “aflatoxin M*” OR AFM* OR AFB* OR Aspergillus)) AND TS = (Feed)) AND TS = (maize OR “zea mays” OR corn)) AND TS = (binding OR adsorbent* OR absorbent* OR clay or HSCAS OR “sodium calcium aluminosilicate” OR charcoal OR bentonite OR zeolite OR clinoptilolite OR silicate* OR chlorofillin OR “lactic acid bacteri*” OR ferment*) |
| Field | TS (topic) |
| Filters | 1 January 2013–26/03/2019 |
| Number of records | 127 |
Point in the food chain: farm.
| Search Date | 25 March 2019 |
|---|---|
| Databases | EBSCOhost |
| Intervention phase | Farm |
| Search string | AB (Aflatoxin OR Aspergillus OR AFM* OR AFB*) AND AB (milk OR cow OR cattle) AND AB (“livestock condition” OR yield* OR breed OR Holstein OR Jersey OR feeding OR feed quality OR lactation OR “carry over”) |
| Field | AB (abstract or author-supplied abstract) |
| Search mode | |
| Filters | 1 January 2013–25 March 2019 |
| Number of records | 85 |
Point in the food chain: farm.
| Search Date | 25 March 2019 |
|---|---|
| Databases | EBSCOhost |
| Intervention phase | Farm |
| Search string | TI (Aflatoxin OR Aspergillus OR AFM* OR AFB*) AND TI (milk OR cow OR cattle) AND TI (“livestock condition” OR yield* OR breed OR Holstein OR Jersey OR feeding OR feed quality OR lactation OR “carry over”) |
| Field | TI (title) |
| Search mode | |
| Filters | 1 January 2013–25 March 2019 |
| Number of records | 9 |
Point in the food chain: farm.
| Search Date | 25 March 2019 |
|---|---|
| Databases | EBSCOhost |
| Intervention phase | Farm |
| Search string | KW (Aflatoxin OR Aspergillus OR AFM* OR AFB*) AND KW (milk OR cow OR cattle) AND KW (“livestock condition” OR yield* OR breed OR Holstein OR Jersey OR feeding OR feed quality OR lactation OR “carry over”) |
| Field | KW (author-supplied keywords)* |
| Search mode | |
| Filters | 1 January 2013–25 March 2019 |
| Number of records | 2 |
* Note that this search field does not exist in EBSCOhost anymore.
Point in the food chain: farm.
| Search Date | 28 March 2019 |
|---|---|
| Databases | Web of Science |
| Intervention phase | Farm |
| Search string | ((TS = ((Aflatoxin OR Aspergillus OR AFM* OR AFB*))) AND TS = ((milk OR cow OR cattle))) AND TS = ((“livestock condition” OR yield* OR breed OR Holstein OR Jersey OR feeding OR feed quality OR lactation OR “carry over”)) |
| Field | TS (topic) |
| Filters | 1 January 2013–28 March 2019 |
| Number of records | 403 |
Title and abstract relevance screening form.
| Question | Options |
|---|---|
| Is the article written in English? |
Yes → Proceed No → Exclude |
| Is the publication type other than peer-reviewed systematic review, risk assessment or primary research (e.g., editorial letter)? | • Yes → Exclude |
| Is contamination of non-cereal commodities discussed? |
Yes → Exclude No → Proceed |
| Is non-feed or non-food use discussed? | • Yes → Exclude |
| Is the publication about aflatoxin measurement with no conclusions on the magnitude of specific intervention effects? | • Yes → Exclude |
| Is the publication about aflatoxin laboratory analysis? | • Yes → Exclude |
| Is the publication about an atomic force microscope? | • Yes → Exclude |
| Does the study discuss industrial utilisation (production of beneficial substances) of | • Yes → Exclude |
Full-text relevance confirmation form.
| Question | Options |
|---|---|
| Did the article investigate the effect of interventions on aflatoxins in maize or milk or milk products? |
Yes → Proceed No, but the results might be extrapolated to maize or milk or milk products → Proceed No, and the results could not be extrapolated to corn or milk or milk products → Exclude |
| Did the article investigate the effect of interventions on aflatoxins? |
Yes → Proceed No, it investigated the effect on survival/death/toxin-producing capacity of Aspergillus species, but the results might be extrapolated to levels of aflatoxins → Proceed No → Exclude |
| Is the text in English? |
Yes → Proceed No → Exclude |
| Are data on the magnitude of effect of the interventions against aflatoxins available for extraction? |
Yes → Proceed No → Exclude |
The data extraction form used during the study had the following fields.
| Field | Attributes |
|---|---|
| Authors | |
| Title | |
| Published | |
| Point in the food chain | Values: storage and feed, farm |
| Intervention category | Values: 1. Feed production, 1.1. High moisture (silage/haylage/pasture), 1.2. Silage additives, 1.3. Low moisture (legume hays/fodder/straw/hulls and shells), 2. Feed additives, 2.1. Technological additives, 2.1.1. Preservatives, 2.1.2. Acidity regulators, 2.1.3. Adsorbents, 2.1.3.1. Bentonites, 2.1.3.2. Silicates, 2.1.4. Enzymes, 2.1.4.1. Extracellular enzymes of |
| Intervention description | free text |
| Target population/sample | free text, e.g., corn, cows, etc. |
| Outcome measured | free text, e.g., aflatoxin M1, aflatoxin G1, Aspergillus spp., etc. |
| Description of the outcome | free text |
| Data extraction from the outcome | free text |
| Study design | Values: 1. Experimental research, 1.1. Randomized controlled trial, 1.2. Nonrandomized controlled trial, 1.3. Challenge trial, 1.4. Quasi-experiment, 2. Observational research, 2.1. Cohort study, 2.2. Case–control study, 2.3. Cross-sectional study, 2.4. Other, 3. Systematic review/meta-analysis, 4. Risk assessment, risk profile, cost–benefit analysis or other risk-based tool |
| Number (magnitude) of samples | free text |
| Level of data reported | Values: individual, group |
| Was the dose response gradient measured? | Values: yes, no, not specified |
| Region of the study conducted | Values: Europe, North America, South America and the Caribbean, Africa, Asia, Australia |
PRISMA 2020 checklist.
| Section and Topic | Item No. | Checklist Item | Page No. Where the Item is Reported |
|---|---|---|---|
|
| |||
| Title | 1 | Identify the report as a systematic review. | 1 |
|
| |||
| Abstract | 2 | See the PRISMA 2020 for Abstracts checklist. | 1 |
|
| |||
| Rationale | 3 | Describe the rationale for the review in the context of existing knowledge. | 2 |
| Objectives | 4 | Provide an explicit statement of the objective(s) or question(s) the review addresses. | 2–3 |
|
| |||
| Eligibility criteria | 5 | Specify the inclusion and exclusion criteria for the review and how studies were grouped for the syntheses. | 3–5, 27 ( |
| Information sources | 6 | Specify all databases, registers, websites, organisations, reference lists and other sources searched or consulted to identify studies. Specify the date when each source was last searched or consulted. | 3, 23–26 ( |
| Search strategy | 7 | Present the full search strategies for all databases, registers and websites, including any filters and limits used. | 3, 23–26 ( |
| Selection process | 8 | Specify the methods used to decide whether a study met the inclusion criteria of the review, including how many reviewers screened each record and each report retrieved, whether they worked independently, and if applicable, details of automation tools used in the process. | 2–3 |
| Data collection process | 9 | Specify the methods used to collect data from reports, including how many reviewers collected data from each report, whether they worked independently, any processes for obtaining or confirming data from study investigators, and if applicable, details of automation tools used in the process. | 4, 28 ( |
| Data items | 10a | List and define all outcomes for which data were sought. Specify whether all results that were compatible with each outcome domain in each study were sought (e.g., for all measures, time points, analyses), and if not, the methods used to decide which results to collect. | 3, |
| 10b | List and define all other variables for which data were sought (e.g., participant and intervention characteristics, funding sources). Describe any assumptions made about any missing or unclear information. | 4, 28 ( | |
| Study risk of bias assessment | 11 | Specify the methods used to assess risk of bias in the included studies, including details of the tool(s) used, how many reviewers assessed each study and whether they worked independently, and if applicable, details of automation tools used in the process. | 4, |
| Effect measures | 12 | Specify for each outcome the effect measure(s) (e.g., risk ratio, mean difference) used in the synthesis or presentation of results. | 2, |
| Synthesis methods | 13a | Describe the processes used to decide which studies were eligible for each synthesis (e.g., tabulating the study intervention characteristics and comparing against the planned groups for each synthesis (item #5)). | not applicable |
| 13b | Describe any methods required to prepare the data for presentation or synthesis, such as handling of missing summary statistics, or data conversions. | not applicable | |
| 13c | Describe any methods used to tabulate or visually display results of individual studies and syntheses. | 4–5, | |
| 13d | Describe any methods used to synthesize results and provide a rationale for the choice(s). If meta-analysis was performed, describe the model(s), method(s) to identify the presence and extent of statistical heterogeneity, and software package(s) used. | not applicable | |
| 13e | Describe any methods used to explore possible causes of heterogeneity among study results (e.g., subgroup analysis, meta-regression). | not applicable | |
| 13f | Describe any sensitivity analyses conducted to assess robustness of the synthesized results. | not applicable | |
| Reporting bias assessment | 14 | Describe any methods used to assess risk of bias due to missing results in a synthesis (arising from reporting biases). | not applicable |
| Certainty assessment | 15 | Describe any methods used to assess certainty (or confidence) in the body of evidence for an outcome. | not applicable |
|
| |||
| Study selection | 16a | Describe the results of the search and selection process, from the number of records identified in the search to the number of studies included in the review, ideally using a flow diagram. | 4 |
| 16b | Cite studies that might appear to meet the inclusion criteria, but which were excluded, and explain why they were excluded. | 3–4 | |
| Study characteristics | 17 | Cite each included study and present its characteristics. | |
| Risk of bias in studies | 18 | Present assessments of risk of bias for each included study. | not applicable |
| Results of individual studies | 19 | For all outcomes, present, for each study: (a) summary statistics for each group (where appropriate) and (b) an effect estimate and its precision (e.g., confidence/credible interval), ideally using structured tables or plots. | not applicable |
| Results of syntheses | 20a | For each synthesis, briefly summarise the characteristics and risk of bias among contributing studies. | not applicable |
| 20b | Present results of all statistical syntheses conducted. If meta-analysis was done, present for each the summary estimate and its precision (e.g., confidence/credible interval) and measures of statistical heterogeneity. If comparing groups, describe the direction of the effect. | not applicable | |
| 20c | Present results of all investigations of possible causes of heterogeneity among study results. | not applicable | |
| 20d | Present results of all sensitivity analyses conducted to assess the robustness of the synthesized results. | not applicable | |
| Reporting biases | 21 | Present assessments of risk of bias due to missing results (arising from reporting biases) for each synthesis assessed. | not applicable |
| Certainty of evidence | 22 | Present assessments of certainty (or confidence) in the body of evidence for each outcome assessed. | not applicable |
|
| |||
| Discussion | 23a | Provide a general interpretation of the results in the context of other evidence. | 22 |
| 23b | Discuss any limitations of the evidence included in the review. | 13 | |
| 23c | Discuss any limitations of the review processes used. | 3 | |
| 23d | Discuss implications of the results for practice, policy, and future research. | 22 | |
|
| |||
| Registration and protocol | 24a | Provide registration information for the review, including register name and registration number, or state that the review was not registered. | not registered |
| 24b | Indicate where the review protocol can be accessed, or state that a protocol was not prepared. | 27–28 ( | |
| 24c | Describe and explain any amendments to information provided at registration or in the protocol. | not applicable | |
| Support | 25 | Describe sources of financial or non-financial support for the review, and the role of the funders or sponsors in the review. | 22 |
| Competing interests | 26 | Declare any competing interests of review authors. | 22 |
| Availability of data, code and other materials | 27 | Report which of the following are publicly available and where they can be found: template data collection forms; data extracted from included studies; data used for all analyses; analytic code; any other materials used in the review. | 28 ( |